GLAaS Algorithm for Quality Assurance in RapidArc Therapy
Author Information
Author(s): Nicolini Giorgia, Vanetti Eugenio, Clivio Alessandro, Fogliata Antonella, Korreman Stine, Bocanek Jiri, Cozzi Luca
Primary Institution: Oncology Institute of Southern Switzerland, Medical Physics Unit, Bellinzona, Switzerland
Hypothesis
Can the GLAaS algorithm effectively verify dosimetric reliability in RapidArc intensity modulated arc therapy?
Conclusion
The GLAaS method is a valid Quality Assurance tool for verifying RapidArc fields, demonstrating high dosimetric accuracy.
Supporting Evidence
- The Gamma Agreement Index was above 95% for all cases at 6 MV.
- GAI averaged 94.9% at 18 MV, indicating high dosimetric accuracy.
- GLAaS allows for direct comparison of measured doses against calculated doses.
- Results showed reproducibility in measurements for short arcs.
- GLAaS does not require additional phantoms for its application.
Takeaway
The GLAaS algorithm helps check if the radiation delivered during cancer treatment is accurate and safe.
Methodology
The GLAaS algorithm was tested on RapidArc fields using amorphous silicon detectors to compare calculated and delivered doses.
Potential Biases
Potential bias from the tongue and groove effect in measurements due to the detector's integration with the gantry.
Limitations
The GLAaS method may mask independent delivery errors due to the composite dosimetric measurement approach.
Participant Demographics
Patients with various tumor sites including brain, head and neck, thorax, and pelvis.
Statistical Information
P-Value
0.001
Statistical Significance
p = 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website